Litcius/Paper detail

Efficacy and safety of immune checkpoint inhibitor monotherapy in pretreated elderly patients with non-small cell lung cancer

Ou Yamaguchi, Hisao Imai, Hiroyuki Minemura, Kensuke Suzuki, Satoshi Wasamoto, Yukihiro Umeda, Takashi Osaki, Norimitsu Kasahara, Junji Uchino, Tomohide Sugiyama, Shinichi Ishihara, Hisashi Ishii, Ichiro Naruse, Keita Mori, Mie Kotake, Kenya Kanazawa, Koichi Minato, Hiroshi Kagamu, Kyoichi Kaira

2020Cancer Chemotherapy and Pharmacology47 citationsDOI

Topics & Concepts

MedicineInternal medicineAdverse effectPneumonitisLung cancerOncologyCancerAnorexiaResponse Evaluation Criteria in Solid TumorsProgressive diseaseChemotherapyLungCancer Immunotherapy and BiomarkersLung Cancer Research StudiesLung Cancer Diagnosis and Treatment
Efficacy and safety of immune checkpoint inhibitor monotherapy in pretreated elderly patients with non-small cell lung cancer | Litcius